Shares of AbbVie have been in rally mode since late October. The company has newer drugs whose revenue could make up for declines due to Humira’s patent expiry.
© 2023 The Abundance Pub. All rights reserved.
All trademarks and service marks are the property of their respective owners. This site is not intended to provide, and does not constitute, medical, health, legal, investment, financial or other professional advice.